Carlsmed (CARL) Accumulated Expenses (2024 - 2026)

Carlsmed's Accumulated Expenses history runs 3 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• Quarterly Accumulated Expenses changed N/A year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (changed N/A YoY) and the FY2025 annual result came in at $3.3 million, up 22.33% from the prior year.
• Accumulated Expenses was $2.8 million for Q1 2026 at Carlsmed, down from $3.3 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $3.3 million in Q4 2025 and bottomed at $1.6 million in Q3 2025.
• A 3-year average of $2.7 million and a median of $2.8 million in 2026 frame the typical range for Accumulated Expenses.
• Peak annual rise in Accumulated Expenses reached 22.33% in 2025, while the deepest fall reached 22.33% in 2025.
• Carlsmed's Accumulated Expenses stood at $2.7 million in 2024, then grew by 22.33% to $3.3 million in 2025, then declined by 15.27% to $2.8 million in 2026.
• Business Quant data shows CARL's Accumulated Expenses at $2.8 million in Q1 2026, $3.3 million in Q4 2025, and $1.6 million in Q3 2025.